Dr. Eric Fauman received his PhD from the University of California, San Francisco for work on protein structure determination by X-ray crystallography. He continued his training with post-doctoral work at the University of Michigan, solving the first crystal structure of a cell cycle phosphatase, CDC25A.
For the past 20 years, Dr. Fauman has been a computational biologist at Pfizer, working with disease biologists to identify and prioritize drug targets to address unmet medical needs. He currently leads a team of computational biologists and geneticists dedicated to Computational Target Validation working across multiple disease areas including cardiovascular and metabolic diseases, neurodegeneration, autoimmune diseases, rare diseases and oncology.
Dr. Fauman is particularly interested in the interpretation of genome-wide association studies (GWAS) in terms of the underlying biological processes and how this information can be used to understand disease pathophysiology.